Affidavit of service of Nancy Gallinger sworn on 18-DEC-2018 on behalf of Plaintiff confirming service of the Notice of Discontinuance upon Defendant by e-mail on 18-DEC-2018 filed on 18-DEC-2018

Discontinuance with Consent on behalf of Plaintiff filed on 18-DEC-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 17-DEC-2018 directing that "The case management conference scheduled for January 3, 2019 is adjourned." placed on file on 17-DEC-2018 Confirmed in writing to the party(ies)

Order (Amended) dated 17-DEC-2018 rendered by Mandy Aylen, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Motion Doc. No. 58 Result: THIS COURT ORDERS that: 1. The questions at Items 5 and 6 of Schedule "A" to Genentech's Motion Record need not be answered (not satisfied as to relevance of the information that is sought; the amino acid sequence has been provided and Genentech can compare to EU and US products). (...) 26. There shall be no costs of this motion. Filed on 17-DEC-2018 entered in J. & O. Book, volume 1395 page(s) 123 - 133 Interlocutory Decision

Ottawa 17-DEC-2018 BEFORE Mandy Aylen, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: Direction and Order to follow held by way of Conference Call in chambers Duration per day: 17-DEC-2018 from 11:02 to 11:04 Courtroom : Judge's Chambers - Ottawa Court Registrar: Kathy Craigie Total Duration: 2min Appearances: Erin Creber 613 786 0222 representing Hoffmann-La Roche Ltd Ms. Dureen and Ms. Hitchman 1 416 777 2204 representing Pfizer Comments: DARS back up not used Heard together with T-401-18, T-869-17, T-876-17 and T-1270-17 Minutes of Hearing entered in Vol. 1013 page(s) 386 - 387 Abstract of Hearing placed on file

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 13-DEC-2018 directing that A case management conference shall be held, by teleconference, on Monday, December 17, 2018 at 11:00 am (Eastern). placed on file on 13-DEC-2018

Letter from parties dated 12-DEC-2018 requesting a short CMC to discuss outstanding issues received on 12-DEC-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 05-DEC-2018 directing that On the consent of the parties, the deadline for service and filing of Pfizer's confidentiality order motion record and proposed timetable for the motion is extended to December 5, 2018. placed on file on 05-DEC-2018

Letter from Pfizer Canada dated 04-DEC-2018 further to the direction of the Court (Aylen, P) dated December 4, 2018. received on 04-DEC-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 03-DEC-2018 directing that The issue of any page limit for expert reports shall be deferred to a later date, following the determination on the motion regarding the number of expert reports. In that regard, the parties shall, by no later than 10 days following the date of determination of the motion regarding the number of expert reports, provide the Court with a status update on this issue. The Court acknowledges the parties¿ submissions regarding the ¿skinny label¿ issue and how it should be addressed at trial. The Court will not issue any further direction on this issue at this time. Genentech may raise any concerns it has regarding this issue as the trial approaches for consideration by the Trial Judge. placed on file on 03-DEC-2018

Letter from Pfizer Canada dated 03-DEC-2018 further to the direction of the Court (Aylen, P) dated November 2, 2018 received on 03-DEC-2018

Letter from Hoffmann-La Roche Limited and Genentech dated 03-DEC-2018 Further to the Courts direction dated November 2, 2018 received on 03-DEC-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 03-DEC-2018 directing that The parties are granted an extension of time to December 17, 2018 to comply with the balance of the COurt's November 2, 2018 direction. placed on file on 03-DEC-2018

Letter from Defendant dated 30-NOV-2018 Requesting an extension until Monday December 3, 2018 to comply with the November 2, 2018 direction of the Court received on 30-NOV-2018

Acknowledgment of Receipt received from Plaintiff with respect to Direction (ID.222) placed on file on 30-NOV-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 30-NOV-2018 directing that "The Court is not presently satisfied, based on Pfizer's submission in its letter dated November 29, 2018, that the highlighted information in the Court's Order dated November 22, 2018 constitutes confidential information warranting protection. Moreover, Genentech and LaRoche do not consent to such information being treated as confidential. Accordingly, should Pfizer continue to seek to have the highlighted information treated as confidential, Pfizer shall, by no later than December 10, 2018, serve and file a formal motion for a confidentiality order in relation to such information, together with a proposed timetable (derived in consultation with Genentech and LaRoche) for the perfection of the motion and the availability of the parties for the hearing of the motion (assuming it is not a motion in writing). The Court shall continue to maintain the highlighted information on a confidential basis pending the outcome of the motion or until December 11, 2018 if no motion is filed." placed on file on 30-NOV-2018 Confirmed in writing to the party(ies)

Sealed envelope pursuant to Order of the Court dated Feb 6, 2018 on behalf of Pfizer Received on 29-NOV-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 28-NOV-2018 directing that A case management conference shall be held, by teleconference, on January 3, 2019 at 9:00 am (Eastern). placed on file on 28-NOV-2018

Letter from Hoffman-La Roche and Genentech dated 26-NOV-2018 regarding portions of the Order on Genentech's Motion to compel are confidential received on 26-NOV-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 22-NOV-2018 directing that The parties shall, by no later than November 29, 2018, advise which portions of the Order on Genetech's motion are confidential so tha tthe Court may issue a public version of the Order placed on file on 22-NOV-2018

CONFIDENTIAL ORDER dated 22-NOV-2018 rendered by Mandy Aylen, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion in writing Doc. No. 66 Result: granted in part Filed on 22-NOV-2018 entered in J. & O. Book, volume 1393 page(s) 14 - 24 Interlocutory Decision

Order dated 22-NOV-2018 rendered by Mandy Aylen, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion in writing Doc. No. 58 Result: granted in part Filed on 22-NOV-2018 entered in J. & O. Book, volume 1393 page(s) 9 - 13 Interlocutory Decision

Memorandum to file from Kathy Craigie dated 20-NOV-2018 Parties provided draft orders, further to the motions to compel heard on November 6, 2018. Draft orders forwarded to the Court. Parties were asked to provide mutual dates of availability for a CMC in the month of January 2019. placed on file.

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 19-NOV-2018 directing that "On the consent of the parties, the parties shall serve and file any motions for leave to file more than five expert reports by January 14, 2019. The delivery of responding and reply motion records shall be in accordance with the timelines prescribed by Rule 369. On the consent of the parties, the deadline for service of responding fact witness affidavits and will say statements shall be October 1, 2019." placed on file on 19-NOV-2018 Confirmed in writing to the party(ies)

Letter from Pfizer dated 16-NOV-2018 writing with consent of Hoffmann-La Roche further to the November 2, 2018 direction of the Court. received on 16-NOV-2018

Letter from Pfizer Canada dated 16-NOV-2018 in relation to the Trial Management Conference. Counsel has provided a seperate letter regarding items b) and c)of the November 2, 2018 direction of the Court (Aylen, P). This letter is to advise of one additional issue that was discussed by the parties after the trial managment conference. received on 16-NOV-2018

Ottawa 06-NOV-2018 BEFORE Mandy Aylen, Prothonotary Language: E Before the Court: Motion Doc. No. 58 on behalf of Plaintiff Result of Hearing: Motion to compel Before the Court: Motion Doc. No. 66 on behalf of Defendant Result of Hearing: Motion to compel held in Court Senior Usher: Denis Martin Duration per day: 07-NOV-2018 from 09:30 to 04:52 Courtroom : Courtroom No. 702, 7th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Kathy Craigie Total Duration: 1day Appearances: Erin Creber and Adam Heckman 613 786 0285 representing Plaintiff Meghan Dureen and Carol Hitchman 416 777 0888 representing Defendant Comments: CONFIDENTIAL IN CAMERA HEARING Heard together with Court file T-402-18, T-869-17, T-876-17 and T-1270-17 Draft order to be submitted by November 20, 2018, along with availability for CMC Minutes of Hearing entered in Vol. 1009 page(s) 463 - 490 Abstract of Hearing placed on file

Letter from Hoffmann-La Roche dated 05-NOV-2018 Re: Motion to compel With confidential attachment - attachment placed in V annex received on 05-NOV-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 02-NOV-2018 directing that Further to the trial management conference held November 2, 2018: (a) The commencement of the trial will not be moved to August 2019. The trial hearing dates will remain as presently scheduled, with the exception that the Court will schedule one additional hearing day for closing arguments (one half day per party) to be held shortly after the conclusion of the trial on a date to be set by the Trial Judge in consultation with the parties. (b) Should any party seek to rely on more than five expert reports, a formal motion must be brought. In that regard, the parties shall meet and confer to discuss the timing of any such motions and shall provide a proposed schedule for the perfection of any such motions by no later than November 16, 2018. (c) The parties shall meet and confer to discuss a date for delivery of any responding fact witness affidavits and any will say statements (for those fact witnesses not providing an affidavit) and shall provide the Court with a proposed timetable for same by no later than November 16, 2018. (d) The parties shall meet and confer to discuss a reasonable page limit for expert reports. In the event that the parties are unable to reach an agreement, the parties shall, by no later than November 30, 2018, provide their respective submissions on this issue for the Court¿s consideration. (e) The parties shall meet and confer to discuss the ¿skinny label¿ issue and how best to address the issue at trial. The parties shall provide the Court with a status update on this issue by November 30, 2018. (f) The Trial Judge will leave open the possibility of hearing any motions for leave to file reply expert evidence in advance of the commencement of trial, rather than as part of the trial itself. (g) Genentech and LaRoche shall, by no later than November 5, 2018, produce to counsel for Pfizer the redacted documents (as addressed at the trial management conference) in electronic format on a counsel¿s and expert¿s eyes only basis. Pfizer shall, by no later than December 7, 2018, provide the Court with a status update on its review of the redactions and whether any motions are anticipated regarding the propriety of the redactions. placed on file on 02-NOV-2018

Ottawa 02-NOV-2018 BEFORE Mandy Aylen, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: Amended Scheduling Order to follow held in Court by way of Conference Call Both Justice Manson and Madam Prothonotary Aylen presiding Duration per day: 02-NOV-2018 from 12:30 to 01:09 Courtroom : Judge's Chambers - Ottawa Court Registrar: Kathy Craigie Total Duration: 39min Appearances: Warren Sprigings 416 938 2273 representing Pfizer Meghan Dureen and Carol Hitchman 416 777 2204 representing Pfizer Tony Creber, John Norman, Adam Heckman 613 786 0140 representing Hoffmann-La Roche Comments: DARS BACK UP USED. Heard together with T-402-18, T-869-17, T-876-18, T-1270-17 Minutes of Hearing entered in Vol. 1009 page(s) 333 - 338 Abstract of Hearing placed on file

Letter from Genentech Inc dated 02-NOV-2018 issues raised for TMC received on 02-NOV-2018

Letter from Pfizer Canada dated 01-NOV-2018 information for the TMC received on 01-NOV-2018

Memorandum to file from Melissa Pilon dated 02-NOV-2018 USB stick containing the motion record Doc 79 was received from the plaintiffs placed on file.

Affidavit of service of Nancy Gallinger sworn on 02-NOV-2018 on behalf of Plaintiff confirming service of the Responding Motion Record and Book of authorities upon Pfizer Canada Inc. by e-mail on 01-NOV-2018 filed on 01-NOV-2018

SEALED Enveloppe containing volume 2 of the Responding Motion Record of Hoffman- La Roche Limited and Genentech inc. filed on 01-NOV-2018

Motion Record in response to Motion Doc. No. 58 containing the following original document(s): 78 Number of copies received: 1 on behalf of Plaintiff filed on 01-NOV-2018

Written Representations contained within a Motion Record on behalf of Plaintiff concerning Motion Doc. No. 58 filed on 01-NOV-2018

Sealed envelope pursuant to Protective Orders on behalf of Defendant (Pfizer) purporting to contain electronic version of doc. 75 Filed on 01-NOV-2018

Solicitor's certificate of service on behalf of Meghan A. Dureen confirming service of doc. 75 and Book of Authorities upon all parties by email on consent on 01-NOV-2018 filed on 01-NOV-2018

Book of Authorities consisting of 1 volume(s) on behalf of Defendant (Pfizer) received on 01-NOV-2018

Sealed envelope pursuant to Protective Orders on behalf of Defendent (Pfizer) purporting to contain Responding Motion Record re: motions to compel answers from discoveries containing docs. 73, 74 Filed on 01-NOV-2018

Written Representations contained within a Motion Record on behalf of Defendant (Pfizer) concerning Motion Doc. No. 58 filed on 01-NOV-2018

Affidavit of Katie Krajacic sworn on 01-NOV-2018 contained within a Motion Record on behalf of Defendant (Pfizer) in opposition to Motion Doc. No. 58 with Exhibits A-E filed on 01-NOV-2018

Acknowledgment of Receipt received from all parties with respect to Direction of the Court (Aylen, P) dated Oct 22, 2018 placed on file on 26-OCT-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 25-OCT-2018 directing that A trial management conference shall be held on November 2, 2018 at 12:30 pm (Eastern) to address the issues raised in Pfizer¿s letter dated October 22, 2018. placed on file on 25-OCT-2018

Letter from Pfizer dated 24-OCT-2018 in response to Genentechs comments in thier October 23rd letter received on 24-OCT-2018

Letter from Genentech Inc dated 23-OCT-2018 In response to the Courts request for availability received on 23-OCT-2018

Letter from Pfizer dated 22-OCT-2018 Requesting a Trial Management Conference received on 22-OCT-2018

Solicitor's certificate of service on behalf of Meghan A. Dureen confirming service of CONFIDENTIAL MOTION RECORD OF PIFZER upon Plaintiff by EMAIL on 17-OCT-2018 filed on 17-OCT-2018

Sealed envelope pursuant to ID# 171 & ID# 172 on behalf of Defendant purporting to contain ELECTRONIC MOTION TO COMPEL GENENTECH, INC AND HOFFMANN-LA ROCHE LIMITED TO PROVIDE ANSWERS TO REFUSED QUESTIONS (1 COPY ONLY SENT TO OTT) Filed on 17-OCT-2018

Book of Authorities consisting of 1 volume(s) on behalf of Defendant (1 COPY ONLY SENT TO OTT) received on 17-OCT-2018

Sealed envelope pursuant to Oral Direction ID#172 on behalf of Defendant purporting to contain CONFIDENTIAL 6 VOL. MOTION RECORD OF DEFENDANT PFIZER CANADA INC. (1 COPY ONLY SENT TO OTT and 1 COPY FOR JUDGE) Filed on 17-OCT-2018

Motion Record containing the following original document(s): 66 67 68 Number of copies received: 1 on behalf of Defendant CONFIDENTIAL 6 VOL. MOTION RECORD SENT TO OTT (1 COPY ONLY) filed on 17-OCT-2018

Written REPRESENTATIONS (CONFIDENTIAL) contained within a Motion Record on behalf of Defendant concerning Motion Doc. No. 66 filed on 17-OCT-2018

Affidavit of Katie Krajacic (CONFIDENTIAL) sworn on 17-OCT-2018 contained within a Motion Record on behalf of Defendant in support of Motion Doc. No. 66 with Exhibits A-S filed on 17-OCT-2018

CONFIDENTIAL - NOTICE OF MOTION contained within a Motion Record on behalf of Defendant - Pfizer Canada Inc. returnable at Special Sitting in Ottawa on 06-NOV-2018 to begin at 09:30 for an Order requiring Genentech and/or Roche Canada to provide answers to refused questions filed on 17-OCT-2018

Affidavit of service of Nancy Gallinger sworn on 17-OCT-2018 on behalf of Plaintiffs confirming service of Doc. 60, 64 and ID 176 upon all parties by email on 16-OCT-2018 filed on 17-OCT-2018

Sealed envelope pursuant to Doc. 35, Order dated May 1, 2018 (Aylen, P.) on behalf of Plaintiffs purporting to contain Motion record containing Docs: 61, 62, 63 (USB attached containing public and protected documents) Filed on 17-OCT-2018

Sealed envelope pursuant to Doc. 35, Order dated May 1, 2018 (Aylen, P.) on behalf of Plaintiffs purporting to contain Written Representations Filed on 17-OCT-2018

Sealed envelope pursuant to Doc. 35 Order dated May 1, 2018 (Aylen, P.) on behalf of Plaintiffs purporting to contain Affidavit of Nancy Gallinger sworn on October 16, 2018, with Exhibits "A" to "W" Filed on 17-OCT-2018

Sealed envelope pursuant to Doc. 35, Order dated May 1, 2018 (Aylen, P.) on behalf of Plaintiffs purporting to contain Notice of Motion for an Order requiring Pfizer Canada Inc. ("Pfizer"), to provide answers to questions refused from the examination for discovery of Ms. Caroline Desrosiers Filed on 17-OCT-2018

Book of Authorities consisting of 1 volume(s) on behalf of Plaintiffs received on 17-OCT-2018

Motion Record containing the following original document(s): 58 59 Number of copies received: 1 on behalf of Plaintiffs (3 Volumes: including two volumes of pleadings) filed on 17-OCT-2018

Affidavit of Nancy Gallinger sworn on 16-OCT-2018 contained within a Motion Record on behalf of Plaintiffs in support of Motion Doc. No. 58 with Exhibits "A" to "W" filed on 17-OCT-2018

Notice of Motion contained within a Motion Record on behalf of Plaintiffs hearing fixed for November 6, 2018 for an Order requiring Pfizer Canada Inc. ("Pfizer") to provide answers to questions refued from the examination for discovery of Ms. Caroline Desrosiers and other relief filed on 17-OCT-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 15-OCT-2018 directing that The parties are permitted to file their motion materials as proposed in Mr. Camenzind¿s letter dated October 15, 2018. placed on file on 15-OCT-2018

Letter from all parties dated 15-OCT-2018 regarding the upcoming motions to compel - seeking direction with respect to the filing of the motion records. received on 15-OCT-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 10-OCT-2018 directing that On the consent of the parties, the following timetable shall apply to the upcoming refusals motions: (a) The parties shall exchange written representations and charts of outstanding questions that will be pursued on refusals motions by October 16, 2018 at 11:00 pm (Eastern). (b) The parties shall serve and file moving motion records by October 17, 2018. (c) The parties shall serve and file responding motion records by November 1, 2018, ensuring that a copy of their written representations and charts are emailed to CMT_Ottawa@cas-satj.gc.ca. (d) The hearing of the motions shall proceed as scheduled on November 6 and 7, 2018. The parties are reminded of the Court¿s Notice to the Parties and the Profession ¿ Case Management: Increased Proportionality in Complex Litigation Before the Federal Court dated June 24, 2015, which provides that: (i) questions should be answered unless clearly improper or prejudicial or would require the disclosure of privileged communication (ii) refusals motions are limited to one hour per day of discovery of each party¿s representative; and (iii) potentially significant cost sanctions may be imposed against unsuccessful/unreasonable parties. The parties are accordingly highly discouraged from submitting hundreds of questions to the Court for determination on the refusals motions. placed on file on 10-OCT-2018

Letter from Hoffmann-La Roche dated 09-OCT-2018 with respect to the motions to compel in T-401-18, T-402-18, T-869-17, T-876-17 and T-1270-17 Parties provide a timetable and indicate if it is acceptable with the Court the case management conference contemplated by the Court will no longer be necessary received on 09-OCT-2018

Order (CONFIDENTIALITY) dated 05-OCT-2018 rendered by Mandy Aylen, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Defendant dated 01-OCT-2018 Result: THIS COURT ORDERS that: 1. The following definitions shall apply for the purposes of this Order: (a) Pfizer Canada Inc. is referred to as "Pfizer". Hossmann-La Roche Limited is referred to a "Roche". Genentech, Inc. is referred to a "Genentech". Each of Pfizer, Roche and Genentech are referred to in the singular as a "Party" and together as "Parties". (...) 12. No costs are payable in respect of this Order. Filed on 05-OCT-2018 entered in J. & O. Book, volume 1386 page(s) 346 - 352 Interlocutory Decision

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 03-OCT-2018 directing that "Given the large number of refusals that remain at issue on the motion in T-1471-17, the Court is not prepared to allocate any portion of the hearing time to address the parties' separate issues in T-401-18 et al. As such, the parties shall forthwith provide their availability for a case management conference next week to address the issues raised in T-401-18 et al." placed on file on 03-OCT-2018 Confirmed in writing to the party(ies)

Letter from Defendant dated 01-OCT-2018 re: confidentiality orders received on 01-OCT-2018

Memorandum to file from Kathy Craigie dated 01-OCT-2018 Counsel for the Defendant confirmed that the request made via letter dated September 28th on behalf of the Plaintiff was not made on behalf of both parties. placed on file.

Letter from Plaintiff dated 28-SEP-2018 regarding the timetable leading up to the hearing of the refusals motion. Requesting 15 minutes at the beginning of the October 4th motion in T-1471-17 to discuss. received on 28-SEP-2018

Affidavit of service of Nancy Gallinger sworn on 26-SEP-2018 on behalf of the Plaintiffs (Hoffmann-La Roche Ltd. & Genentech Inc.) confirming service of document no. 55 upon the Defendant (Pfizer Canada Inc.) by e-mail on 26-SEP-2018 filed on 26-SEP-2018

Amended Reply to the Second Amended Statement of Defence on behalf of the Plaintiffs (Hoffmann-La Roche Ltd. & Genentech Inc.) Filed on 26-SEP-2018

Communication to the Court from the Registry dated 21-SEP-2018 re: file sent to Court re: letters dated Sept 20, 2018

Letter from Defendant dated 21-SEP-2018 further to the letter on behalf of the Plaintiff dated September 20, 2018 received on 20-SEP-2018

Letter from Plaintiff dated 20-SEP-2018 Counsel writes to request the Court postpone the hearing of any refusal motions by the parties from the currently scheduled dates of November 6 & 7, 2018. received on 20-SEP-2018

Solicitor's certificate of service on behalf of Meghan A. Dureen confirming service of Second Amended Statement of Defence upon Defendant by email on 17-SEP-2018 filed on 17-SEP-2018

Second Amended Statement of Defence filed on 17-SEP-2018

Affidavit of service of Nancy Gallinger sworn on 28-AUG-2018 on behalf of Plaintiff confirming service of the Plaintiff's Amended Statement of Claim upon Defendant by email on 28-AUG-2018 filed on 29-AUG-2018

Consent on behalf of Defendant to the Plaintiffs Second Amended Statement of Claim filed on 29-AUG-2018

Second Amended Statement of Claim filed on 29-AUG-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 30-AUG-2018 directing that The Court has considered the submissions of the parties dated August 29, 2018 in relation to the reallocation of discovery time. The Court ordered the maximum duration of examinations for discovery at four days for corporate representatives and a half day per inventor and that if a named inventor was also produced as the corporate representative, a party would still have 1.5 days to examine that individual. This order was made based on four patents being at issue in the proceedings. Since that time, the claims related to the 596 Patent have been discontinued and as a result, there now remains only three patents at issue in these proceedings. While I would have found that Pfizer's entitlement to days of discovery should be reduced as a result of the discontinuance of the claims related to the 596 Patent, I am satisfied that there was a clear lack of communication and understanding between the parties as to the impact of the discontinuance on the discovery days and that Pfizer proceeded to allocate its discovery time based on its understanding/misunderstanding. I find that in the circumstances, it would be prejudicial to not permit Pfizer to continue with the original amount of discovery time allocated. In making this finding, I would also stress that these files have been plagued by a lack of cooperation and communication between the parties which has resulted in a number of disputes requiring the Court's intervention, this being yet another one. Had the parties properly communicated regarding this issue before the discoveries proceeded, this issue could have been avoided. Accordingly, Pfizer is entitled to further discovery as requested in its letter dated August 29, 2018. placed on file on 30-AUG-2018

Letter from Defendant Pfizer Canada Inc dated 29-AUG-2018 fruther to the Courts direction of August 22, 2018. Counsel encloses previous correspondence between parties received on 29-AUG-2018

Letter from The Plaintiff, Hoffmann-La Roche Limited and Genentech dated 29-AUG-2018 further to the Courts direction dated August 22, 2018 with respect to discovery received on 29-AUG-2018

Acknowledgment of Receipt received from all parties with respect to re: direction of the Court (Aylen, P) dated August 29, 2018 placed on file on 29-AUG-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 29-AUG-2018 directing that On the consent of the parties, the Plaintiffs are granted leave to serve and file, by no later than August 31, 2018, a Second Amended Statement of Claim in each action in the form agreed to by the parties. Pfizer shall serve and file any amended Statement of Defence that makes amendments that are consequential to the amendment of the Plaintiffs¿ pleading by no later than September 17, 2018. Any further, non-consequential amendments that Pfizer may seek to make may be included in its amended pleading if on the consent of the parties or with leave of the Court, or by way of a further amendment at a at a later point in time on the consent of the parties or with leave of the Court. placed on file on 29-AUG-2018

Letter from Plaintiff, Hoffmann-La Roche dated 28-AUG-2018 further to the Courts direction dated August 22, 2018 received on 28-AUG-2018

Letter from The Defendant, Pfizer Canada Inc dated 28-AUG-2018 in response to the direction of the Court (Aylen, P) dated August 22, 2018 received on 28-AUG-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 22-AUG-2018 directing that "The Court is in receipt of letters from both parties dated August 21, 2018. Genentech shall, by no later than August 24, 2018, provide to Pfizer a substantive response to Pfizer's letter dated August 9, 2018 regarding the reallocation of the day of corporate discovery arising from the discontinuance of claims related to the 596 Patent. If further discussions are to be held between the parties to address this issue, they shall be held by no later than August 28, 2018. The parties shall provide the Court with a further status update on this issue by August 29, 2018. Counsel for Pfizer shall forthwith obtain instructions from Pfizer regarding the narrowing of the claims, the proposed amended pleadings and a timetable for amended responding pleadings. There is no value in holding a case management conference at this time if Pfizer has no instructions in relation to these issues. The parties shall confer to telephone on these issues and provide the Court with a status report by no later than August 28, 2018." placed on file on 22-AUG-2018

Letter from Springings Law dated 21-AUG-2018 Response to letter from Gowling dated August 21, 2018. Springings Law responds that the counsel did not provide the letter for comment ahead of time and that the letter contained inaccurate information with respect to Pfizer's position on a number of issues. received on 21-AUG-2018

Letter from Gowling WLG dated 21-AUG-2018 Letter requesting the Case Management Judge's assistance in resolving minor administrative issues in the actions in T-401-18/T-402-18/T-1269-17. received on 21-AUG-2018

Acknowledgment of Receipt received from the parties with respect to Order doc. 49 dated 01-AUG-2018 rendered by the Honourable Mr. Justice Manson placed on file on 01-AUG-2018

Order dated 01-AUG-2018 rendered by The Honourable Mr. Justice Manson Matter considered without personal appearance The Court's decision is with regard to Motion ex proprio motu Result: THIS COURT ORDERS that: 1. Further document production by Genentech and Roch, shall be in accordance to schedule I hereto, and shall be made no later than 3 days prior to oral discoveries are commenced; 2. No costs are awarded. Filed on 01-AUG-2018 copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1379 page(s) 487 - 497 Interlocutory Decision

Toronto 20-JUL-2018 BEFORE The Honourable Mr. Justice Manson Language: E Before the Court: Motion ex proprio motu Result of Hearing: Matter reserved held in Court Senior Usher: Anne Brzuchalski Duration per day: 20-JUL-2018 from 09:30 to 11:53 Courtroom : Courtroom No. 5-A - Toronto Court Registrar: Abigail Grimes Total Duration: 2h 23mins Appearances: Carol Hitchman / Meghan Dureen / Nathanial Dillonsmith 416-777-0888 representing Pfizer Canada Inc. Anthony Creber / Frederick Lussier / Justin Smith 613-233-1781 representing Genentech Inc., et al Comments: Parties are to provide the Court with what has been agreed upon and address any confidentiality issues on or before 25-JUL-2018 Matter heard together with T-876-17, T-1269-17, T-1270-17, T-869-17 & T-402-18 DARS Z006207 Minutes of Hearing entered in Vol. 1003 page(s) 200 - 206 Abstract of Hearing placed on file

Letter from Genentech, Inc. dated 27-JUL-2018 further to motion heard 20-JUL-2018 and Pfizer's letter dated 27-JUL-2018 received on 27-JUL-2018

Letter from Pfizer Canada Inc. dated 27-JUL-2018 further to the motion heard 20-JUL-2018 with attachments received on 27-JUL-2018

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 25-JUL-2018 directing that further to correspondence from the parties, the extension of time is granted placed on file on 25-JUL-2018 Confirmed in writing to the party(ies)

Letter from Pfizer Canada Inc. dated 25-JUL-2018 requesting an extension of time to provide the draft Order to the Court further to the motion heard 20-JUL-2018, on behalf of the parties received on 25-JUL-2018

Confidential Pfizer's Chart by Categories received at hearing on 20-JUL-2018

Letter from Defendant dated 19-JUL-2018 further to Direction of Manson, J. dated 17-JUL-2018. Copy of letter and confidential enclosures placed in V annexes. received on 19-JUL-2018

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 19-JUL-2018 directing that The Court requires that based on the parties' submissions of July 13 and July 16, 2018, Pfizer is to advise the Court what, specifically, remains in issue with respect to their motions for document production, by July 19, 2018. Any production determined to be unnecessary or irrelevant will attract significant cost consequences, payable forthwith. Similarily, Genentech shall advise the Court of any further productions that will be made in response to Pfizer's outstanding requests and when, if any further productions are to be made, those productions will be made. Any refusals found to be unjustified will also attract significant cost consequences, payable forthwith. placed on file on 17-JUL-2018 Confirmed in writing to the party(ies)

Letter from Hoffmann-La Roche Ltd dated 19-JUL-2018 Pursuant to the direction of the Court (Manson, J) dated July 17, 2018 received on 19-JUL-2018

Letter from Pfizer Canada dated 13-JUL-2018 Status update pursuant to the Order of the Court (Aylen, P) dated June 22, 2018. Copy of letter and confidential enclosures placed in V annexes. received on 13-JUL-2018

Affidavit of service of Nancy Gallinger sworn on 13-JUL-2018 on behalf of Plaintiff confirming service of Doc. No. 47 Amended Reply upon Defendant by e-mail on 13-JUL-2018 filed on 13-JUL-2018

Amended Reply with proof of service upon Defendant on 13-JUL-2018 filed on 13-JUL-2018

Solicitor's certificate of service on behalf of Meghan A. Dureen confirming service of Doc 45 upon Plaintiff by email on 03-JUL-2018 filed on 03-JUL-2018

Amended Defence filed on 03-JUL-2018

Covering letter from Plaintiff (Fax cover) dated 26-JUN-2018 concerning Request for Copy of Audio Recording dated June 26, 2018 placed on file on 26-JUN-2018

Letter from Cousnel for Hoffmann-La Roche dated 20-JUN-2018 re: proposed motion for further documents from Pfizer. received on 20-JUN-2018

Acknowledgment of Receipt received from all parties with respect to Order of the Court (Aylen, P) dated June 22, 2018 placed on file on 22-JUN-2018

Order dated 22-JUN-2018 rendered by Mandy Aylen, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Case Management Conference Result: Defendant to pay hte Plaintiff forthwith their costs of the case management conference at $2,000.00 P's addition documents July 9, 2018 Defendant status update July 13, 2018 Plaintiffs granted extension of time to July 16, 2018 to serve and file responding record Defanendants motion to be heard before Justice Manson July 20, 2018 at 9:30 a.m. TOR Filed on 22-JUN-2018 entered in J. & O. Book, volume 1374 page(s) 203 - 204 Interlocutory Decision

Ottawa 22-JUN-2018 BEFORE Mandy Aylen, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: Order to follow held by way of Conference Call in chambers Duration per day: 22-JUN-2018 from 01:00 to 01:36 Courtroom : Judge's Chambers - Ottawa Court Registrar: Kathy Craigie Total Duration: 36min Appearances: Ms. Hitchman, Mr. Sprigings, Mr. Dillonsmith 416 777 2204 representing Pfizer Canada Mr. Creber, Mr. Norman, Mr. Lussier 613 786 0140 representing Hoffmann- La Roche Comments: DARS back up recorder used. Heard together with Court Files T-402-18, T-402-18, T-869-17, T-876-17, T-1269-17 and T-1270-17 - Justice Manson participated in the CMC Minutes of Hearing entered in Vol. 1000 page(s) 452 - 457 Abstract of Hearing placed on file

Letter from Hoffmann-La Roche Limited dated 22-JUN-2018 In advance of the CMC, with respect to Pfizer¿s motion for further and better affidavit of documents. received on 22-JUN-2018

Letter from Pfizer Canada dated 20-JUN-2018 In response to the letter from Counsel, Genentech Inc. dated June 19, 2018, regarding Pfizer`s motion currently scheduled for July 6, 2018. received at hearing on 21-JUN-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 20-JUN-2018 directing that A case management conference shall be held on Friday, June 22, 2018 at 1:00 pm (Eastern) to address the issues raised in Mr. Lussier¿s letter dated June 19, 2018. Both Case Management Judge Aylen and Justice Manson will be presiding. placed on file on 20-JUN-2018

Letter from Pfizer dated 20-JUN-2018 Pursuant to the Direction of the Court of today¿s date, this is to advise that counsel for Pfizer are available all day on Friday June 22, 2018 for a case management conference. received on 20-JUN-2018

Acknowledgment of Receipt received from all parties with respect to Direction of the Court (Aylen, P) dated June 20, 2018 placed on file on 20-JUN-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 20-JUN-2018 directing that Pfizer shall, by no later than 9:00 am (Eastern) on June 21, 2018, provide a letter to the Court addressing the concerns raised by Genentech/Roche in their letter dated June 19, 2018. Pfizer shall also, by no later than 4:00 pm today, provide its availability for a case management conference on Friday to address this issue (should the Court determine that a case management conference is needed). placed on file on 20-JUN-2018

Letter from Hoffmann-La Roche dated 19-JUN-2018 With respect to the motions for documents by Pfizer Canada Inc. Counsel confirms the scope of the motion discussed during the CMC is significantly different from what Pfizer now seeks to do. received on 19-JUN-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 11-JUN-2018 directing that Further to the case management conference held June 11, 2018: (a) The parties shall settle all discovery dates by June 15, 2018. (b) With respect to Genentech¿s pending motion: a. Pfizer shall serve a list of its category 4 and 5 documents over which it claims privilege (with the exception of those that are communications with external counsel) by June 15, 2018. b. Genentech shall serve and file its complete moving record by June 22, 2018. c. Pfizer shall serve and file its responding motion record by June 29, 2018. (c) With respect to Pfizer¿s pending motion: a. Pfizer shall serve and file its complete moving record by June 18, 2018 b. Genentech shall serve and file its responding record by June 27, 2018. (d) Both Pfizer¿s and Genentech¿s motion shall be heard on July 6, 2018 from the Federal Court in Ottawa commencing at 1:30 pm (Eastern) for a maximum duration of three hours. placed on file on 11-JUN-2018

Ottawa 11-JUN-2018 BEFORE Mandy Aylen, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: Direction to follow held by way of Conference Call in chambers Duration per day: 11-JUN-2018 from 03:00 to 03:47 Courtroom : Judge's Chambers - Ottawa Court Registrar: Kathy Craigie Total Duration: 47min Appearances: Anthony Creber 613 786 0140 representing Plaintiff Frederic Lussier 613 786 0140 representing Plaintiff Warren Sprigings 1 416 777 2273 representing Defendant Carol Hitchman 1 416 777 2273 representing Defendant Nathaniel Dillonsmith 1 416 777 2273 representing Defendant Comments: DARS back up not used at request of Court. Heard together with T-402-18, T-869-17, T-876-17, T-1269-17 and T-1270-17 Minutes of Hearing entered in Vol. 1000 page(s) 24 - 29 Abstract of Hearing placed on file

Memorandum to file from Kathy Craigie/Ottawa dated 11-JUN-2018 "We confirm that the Defendant, Pfizer Canada Inc. does not have concerns regarding the confidentiality of the DARS recording of May 29, 2018 and the recording can be made public." -this information was forwarded to the Court, who confirmed a formal direction would not issue, and that a notation of the file is acceptable. placed on file.

Memorandum to file from K. Craigie dated 06-JUN-2018 The Court has indicated that a copy of the Hearing can be made for counsel for the Plaintiff but would like to remind counsel that this audio is confidential. placed on file.

Request on behalf of the Plaintiff for a copy of the May 29, 2018 Audio Recording of the motion heard at Ottawa. Audio confidential, until which time counsel for the Defendant receives confirmation from their client. placed on file on 05-JUN-2018

Communication to the Court from the Registry dated 05-JUN-2018 re: File sent to Court re: CMC fixed for June 11, 2018 at 3 pm

Acknowledgment of Receipt received from all parties with respect to direction of the Court (Aylen, P) dated June 5, 2018 placed on file on 05-JUN-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 05-JUN-2018 directing that A case management conference shall be held, by teleconference, on June 11, 2018 at 3:00 pm (Eastern) to address the schedule for the motions for further and better affidavits of documents. The parties shall, in advance of the case management conference, discuss by telephone the parties' respective timetables to determine whether a consensus can be reached for the timing of both motions. However, the Court will be looking to schedule the hearing of both motions as soon as possible so as to preserve the existing discovery schedule. Complete moving motion records should be delivered by no later than the end of next week and if the motions are to be heard orally, the proposed timetable shall not include a right of reply. placed on file on 05-JUN-2018

Letter from Pfizer Canada dated 04-JUN-2018 in response to the letter on behalf of Hoffmann-La Roche dated June 4, 2018 received on 04-JUN-2018

Letter from Hoffmann-La Roche Limited dated 04-JUN-2018 further to the scheduling order dated May 29, 2018, where the Court reqeusted that counsel advise if a motion for further and better affidavits of documents would be required. Counsel confirms that Pfizer has not yet provided clarification or further information with related to the documents requested. Because cousel does not have a response as to why the documents have not been produced, counsel is enclosing Notices of Motions. received on 04-JUN-2018

Letter from Defendant dated 30-MAY-2018 Letter requesting the audio of the hearing of May 29, 2018 Although the Audio was confidential, A CD of the audio was prepared for counsel for the Defendant (in order for counsel to detemine if the matter /audio of the hearing should remain confidential). received on 31-MAY-2018

Affidavit of service of Nancy Gallinger sworn on 31-MAY-2018 on behalf of the Plaintiffs confirming service of document no. 42 upon Defendant by e-mail on 31-MAY-2018 filed on 31-MAY-2018

Amended Statement of Claim filed on 31-MAY-2018

Bill of costs of Plaintiff received on 29-MAY-2018

Letter from Plaintiff to The Federal Court (VIA EMAIL) dated 29-MAY-2018 Attaching the Plainiffs Bill of Costs for Motion doc 9//Pursuant to the direction of the Court (Aylen, P) dated May 23, 2018. received on 29-MAY-2018

Acknowledgment of Receipt received from all parties with respect to order of the Court (Aylen, P) dated May 29, 2018 placed on file on 30-MAY-2018

Order dated 30-MAY-2018 rendered by Mandy Aylen, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 9 Result: dismissed Filed on 29-MAY-2018 entered in J. & O. Book, volume 1371 page(s) 59 - 60 Interlocutory Decision

Ottawa 29-MAY-2018 BEFORE Mandy Aylen, Prothonotary Language: E Before the Court: Motion Doc. No. 9 on behalf of Defendant Result of Hearing: Matter dismissed held in Court by way of video conference Senior Usher: Roger Heroux Duration per day: 29-MAY-2018 from 02:00 to 03:55 Courtroom : Videoconference Room 703 - 7th Floor - Thomas D'Arcy McGee Bldg. - Ott Court Registrar: Kathy Craigie Total Duration: 1hr55min Appearances: Mr. Creber and Mr. Camenzind 1 613 786 0140 representing Plaintiff Ms. Hitchman and Ms. Dureen 416 777 2204 representing Defendant Comments: DARS used. HEARING TO REMAIN CONFIDENTIAL UNTIL COUNSEL FOR THE DEFENDANT CONFRIMS IF THE AUDIO CAN BE MADE PUBLIC Heard together with Court file T-402-18 Minutes of Hearing entered in Vol. 999 page(s) 139 - 145 Abstract of Hearing placed on file

SCHEDULING ORDER - AMENDMENT NO. 1 dated 29-MAY-2018 rendered by Mandy Aylen, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Case Management Conference Result: Please see attached for complete "amended" timetable granted in part Filed on 29-MAY-2018 entered in J. & O. Book, volume 1371 page(s) 8 - 14 Interlocutory Decision

Bill of costs of Defendant The Defendant (further to the direction of the Court Aylen, P May 23, 2018) received on 29-MAY-2018

Solicitor's certificate of service on behalf of Meghan A. Dureen confirming service of document no. 38 upon all parties by e-mail (on consent) on 23-MAY-2018 filed on 23-MAY-2018

Written Written Supplemental Representations on behalf of Defendant concerning Motion Doc. No. 9 filed on 23-MAY-2018

Affidavit of service of Nancy Gallinger sworn on 25-MAY-2018 on behalf of Plaintiff confirming service of doc. no. 36 upon Defendant by email on consent on 25-MAY-2018 filed on 25-MAY-2018

Written Summplemental Submissions on behalf of Plaintiff concerning Motion Doc. No. 9 filed on 25-MAY-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 23-MAY-2018 directing that The parties shall be prepared to address the issue of costs at the hearing of the motions to strike on May 29, 2018 and shall provide the Court with a detailed bill of costs at the hearing.¿ placed on file on 23-MAY-2018

Acknowledgment of Receipt received from all parties with respect to Direction of the Court (Aylen, P) in Court files T-401-18, T-402-18 placed on file on 18-MAY-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 17-MAY-2018 directing that Pfizer's motion to strike shall be heard on May 29, 2018 for 2 hours commencing at 2:00 pm (Eastern) from the Federal Court in Ottawa, with video-conferencing from the Federal Court in Toronto. Pfizer shall serve and and file its supplemental submissions by May 23, 2018 and Genentech shall serve and file its supplemental submissions by May 25, 2018." placed on file on 17-MAY-2018

Ottawa 17-MAY-2018 BEFORE Mandy Aylen, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: direction to follow held by way of Conference Call Duration per day: 17-MAY-2018 from 02:01 to 02:50 Courtroom : Judge's Chambers - Ottawa Court Registrar: Chantal Mainville Total Duration: 49m Appearances: John Norman, Anthony Creber, Frédéric Lussier 613-786-0140 representing Plaintiff Meghan Dureen, Carol Hitchman 416-777-2204 representing Respondent Comments: DARS not used at the request of the Court Minutes of Hearing entered in Vol. 998 page(s) 256 - 261 Abstract of Hearing placed on file

Letter from Defendant dated 17-MAY-2018 regarding a proposed schedule in advance of the case management conference. Scanned to P. Aylen. received on 17-MAY-2018

Letter from Plaintiff dated 17-MAY-2018 proposed agenda on behalf of parties re: CMC fixed for 2pm today, May 17, 2018 received on 17-MAY-2018

Communication to the Court from the Registry dated 14-MAY-2018 re: file sent to Court re: CMC fixed for May 17, 2018

Acknowledgment of Receipt received from all parties with respect to Direction of the Court (Aylen, P) dated May 14, 2018 placed on file on 14-MAY-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 14-MAY-2018 directing that A case management conference shall be held, by teleconference, on May 17, 2018 at 2:00 pm (Eastern). The parties shall, in advance of the case management conference, discuss the additional concerns raised by Pfizer regarding the proposed amended pleadings and be prepared to address them at the the case management conference. placed on file on 14-MAY-2018

Letter from Defendant dated 13-MAY-2018 In response to the Oral Direction of the Court (Aylen, P) dated April 30, 2018 re: Pfizers motion to strike received on 14-MAY-2018

Letter from Plaintiff dated 11-MAY-2018 On April 30, 2018 the Court (Aylen, P) adjourned Pfizer's motion to strike in these actions, and requested parties attempt to resolve this motion via amendments to the statement of claim. received on 11-MAY-2018

Letter from The plaintiffs, Hoffmann-La Rouche dated 02-MAY-2018 Further to the Order of the Court (Aylen, P) dated April 23, 2018 Further to the Order of the Court dated April 23, 2018. Parties proposed a jointly proposed timetable. received on 02-MAY-2018

Acknowledgment of Receipt received from all parties with respect to Order of the Court (Aylen, P) dated May 1, 2018 placed on file on 01-MAY-2018

ORDER (Protective Order) dated 01-MAY-2018 rendered by Mandy Aylen, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion in writing Doc. No. 20 Result: Counsel for the Plaintiffs advised they are agreeable to the issuance of the Protective Order in the form proposed by the Defendant, with exception of paragraph 25 (Please see attached for terms of protective order) Filed on 01-MAY-2018 entered in J. & O. Book, volume 1367 page(s) 338 - 352 Interlocutory Decision

Letter from Sprigings dated 01-MAY-2018 requesting DARS recording of April 30th hearing [[scanned to K. Craigie]] received on 01-MAY-2018

Ottawa 30-APR-2018 BEFORE Mandy Aylen, Prothonotary Language: E Before the Court: Motion Doc. No. 9 on behalf of Defendant Result of Hearing: Matter adjourned sine die Before the Court: Motion Doc. No. 20 on behalf of Plaintiff Result of Hearing: Matter reserved held in Court Senior Usher: Pierre Gendron Duration per day: 30-APR-2018 from 09:30 to 10:15 Courtroom : Courtroom No. 702, 7th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Kathy Craigie Total Duration: 45min Appearances: Anthony Creber, Frederic Lussier, Alexander Camenzind 613 233 1781 representing Plaintiff Meghan A. Dureen and Carol Hitchman 416 777 0888 representing Defendant Comments: Heard together with T-402-18. DARS used. Minutes of Hearing entered in Vol. 996 page(s) 493 - 497 Abstract of Hearing placed on file

Letter from Plaintiff dated 27-APR-2018 In response to Ms. Dureen's letter. Counsel confirms they disagree with the position and request outlined in Ms. Dureen's letter. received on 27-APR-2018

Letter from Defendant dated 27-APR-2018 with respect to the affidavits of documents and the schedule one productions received on 27-APR-2018

Solicitor's certificate of service on behalf of Defendant confirming service of doc.33 and Book of Authorities upon Plaintiff by on consent on 26-APR-2018 filed on 26-APR-2018

Book of Authorities consisting of 1 volume(s) on behalf of Defendant received on 26-APR-2018 Sent directly to Presiding Judge

Motion Record in response to Motion Doc. No. 20 Number of copies received: 3 on behalf of Defendant filed on 26-APR-2018

Written Representations contained within a Motion Record on behalf of Defendant concerning Motion Doc. No. 20 filed on 26-APR-2018

Affidavit of Katie Krajacic sworn on 26-APR-2018 contained within a Motion Record on behalf of Defendant in opposition to Motion Doc. No. 20 with Exhibits A-Q filed on 26-APR-2018

Acknowledgment of Receipt received from all parties with respect to the Scheduling Order of the Court (Aylen, P) dated April 23, 2018 placed on file on 25-APR-2018

Scheduling Order dated 25-APR-2018 rendered by Mandy Aylen, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Case Management Conference Result: The hearing of Pfizer's motion to strike - April 30, 2018 The hearing of Genentech/Roche's motion to vary Pfizer's confidentiality rules and for a protective order - April 30,2018 -Jointy proposed timetable - May 2, 2018 Hearing of the Refusals motions November 6-7, 2018 with venue to be determined Trial in this matter fixed for November 18, 2019 for a duration of 10 days in Toronto Filed on 23-APR-2018 entered in J. & O. Book, volume 1367 page(s) 56 - 62 Interlocutory Decision

Ottawa 23-APR-2018 BEFORE Mandy Aylen, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: Scheduling Order to issue held by way of Conference Call in chambers Duration per day: 23-APR-2018 from 01:00 to 01:35 Courtroom : Judge's Chambers - Ottawa Court Registrar: Kathy Craigie Total Duration: 35min Appearances: Anthony Creber 613 786 0140 representing Plaintiff Frederick Lussier 613 786 0140 representing Plaintiff Warren Sprigings 416 777 2273 representing Defendant Carol Hitchman 416 777 2273 representing Defendant Meghan Dureen 416 777 2273 representing Defendant Comments: DARS back up not used, at the request of the Court Heard together with T-402-18 Minutes of Hearing entered in Vol. 996 page(s) 355 - 360 Abstract of Hearing placed on file

Covering letter from Plaintiff dated 20-APR-2018 concerning Plaintiffs Responding Motion Records placed on file on 20-APR-2018

Affidavit of service of Law Clerk Employed at the firm Gowling WLG sworn on 20-APR-2018 on behalf of Plaintiff confirming service of Public Version of Volumes 2 and 3 Responding Motion Record upon Defendant by electronically on 20-APR-2018 filed on 20-APR-2018

Motion Record containing the following original document(s): 27 Number of copies received: 1 on behalf of Plaintiff filed on 20-APR-2018

Written Representations contained within a Motion Record on behalf of Plaintiff concerning Motion Doc. No. 20 filed on 20-APR-2018

Motion Record containing the following original document(s): 25 Number of copies received: 1 on behalf of Plaintiff filed on 20-APR-2018

Affidavit of Nancy Gallinger sworn on 13-APR-2018 contained within a Motion Record on behalf of Plaintiff in support of Motion Doc. No. 20 with Exhibits A to Q filed on 20-APR-2018

Letter from Plaintiff dated 19-APR-2018 further to the Order of the Court dated April 3, 2018, in advance of the Case Management Conference, scheduled for April 23, 2018 in these actions. received on 19-APR-2018

Communication to the Court from the Registry dated 19-APR-2018 re: file sent to Court re: CMC fixed for April 23, 2018 at 1 pm File sent to Court with T-402-18

Affidavit of service of Nancy Gallinger sworn on 17-APR-2018 on behalf of Plaintiff confirming service of Plaintiff's Motion for a Protective Order upon Defendant by electronically, in accordance with the Consent to Electronic Service on 17-APR-2018 filed on 17-APR-2018

Covering letter from Plaintiff dated 19-APR-2018 concerning Motion Record (doc 23) placed on file on 17-APR-2018

Motion Record containing the following original document(s): 20 21 22 Number of copies received: 3 on behalf of Plaintiff filed on 17-APR-2018

Written Representations contained within a Motion Record on behalf of Plaintiff concerning Motion Doc. No. 20 filed on 17-APR-2018

Affidavit of Nancy Gallinger sworn on 17-APR-2018 contained within a Motion Record on behalf of Plaintiff in support of Motion Doc. No. 20 with Exhibits A-K filed on 17-APR-2018

Notice of Motion contained within a Motion Record on behalf of Plaintiff returnable at Special Sitting in Ottawa on 30-APR-2018 to begin at 09:30 for an Order Pursuant to section 5(3.7) of the Patented Medicines (Notice of Compliance) Regulations varying the Confidentiality rules and other relief filed on 17-APR-2018

Letter from Defendant dated 19-APR-2018 In response to the Order of the Court (Aylen, P) dated April 19, 2018. (paragraphs 3, 4 and 8) Counsel confirms that they can not yet advise as to a revised proposed timetable. Counsel confirms they will endeavor to discuss with counsel for the Plaintiffs in advance of the CMC scheduled for Monday April 23, 2018 in order to update the Court and hopefully provide a revised schedule. Regardless counsel feels that the CMC is necessary absent an updated timetable to faciliate the progress of these actions. received on 19-APR-2018

Memorandum to file from Kathy Craigie dated 18-APR-2018 Letter from the Defendant, dated April 18, 2018 was sent to Court. The Court confirmed that counsel in Toronto are welcome to appear in person in Ottawa on April 30, 2018. Counsel was advised on todays date; a formal direction will not issue. TRIAL JA/Ottawa Courtrooms/Support IT and TOR was notified of the change. VC arrangements were cancelled. placed on file.

Letter from Defendant dated 18-APR-2018 requesting to appear in person at Ottawa (rather than VC from Toronto)for the motion fixed for April 30, 2018. received on 18-APR-2018

Acknowledgment of Receipt received from all parties with respect to Direction of the Court (Aylen, P) dated April 18, 2018 placed on file on 18-APR-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 18-APR-2018 directing that The Plaintiffs' motion addressing Pfizer's confidentiality rules and seeking a protective order shall be heard on April 30, 2018 in accordance with the timetable already established by the Court. placed on file on 18-APR-2018

Letter from Plaintiff dated 18-APR-2018 in response to Pfizer's letter of April 17, 2018. Counsel submits it is most efficient to to hear the motion on April 30, 2018 received on 18-APR-2018

Letter from Defendant dated 17-APR-2018 in response to the Order of the Court (Aylen, P) dated April 3, 2018 and also in response to the Direction of the Court (Aylen, P) dated April 9, 2018. Counsel submits if the Court is to hear the motion for a protective order rather than a motion to vary Pfizer's confidentiality rules, such motion be heard at a later date (rather than the April 30, 2018 date held for the motion to vary a party's confidentiality rules) received on 17-APR-2018

Affidavit of service of Nancy Gallinger sworn on 13-APR-2018 on behalf of Plaintiff confirming service of Doc. no. 18 and ID#43 upon Defendant by email on consent on 13-APR-2018 filed on 13-APR-2018

Book of Authorities consisting of 1 volume(s) on behalf of Plaintiff received on 13-APR-2018

Motion Record in response to Motion Doc. No. 9 containing the following original document(s): 16 17 Number of copies received: 3 on behalf of Plaintiff (3 volumes - volumes 2 and 3 are confidential) filed on 13-APR-2018

Written Representations contained within a Motion Record on behalf of Plaintiff concerning Motion Doc. No. 9 filed on 13-APR-2018

Affidavit of Nancy Gallinger sworn on 13-APR-2018 contained within a Motion Record on behalf of Plaintiff in opposition to Motion Doc. No. 9 with Exhibits A-Q filed on 13-APR-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 10-APR-2018 directing that It would appear from the correspondence from the parties that further discussions need to occur regarding the potential amendment of the confidentiality rules imposed by the parties in relation to their respective documents. Accordingly, the parties shall continue their discussions with a view to reaching a resolution of these issues. In the event that either party determines that a motion to vary the confidentiality rules is required, any moving record shall be served and filed by April 17, 2018. Any responding record shall be served and filed by April 26, 2018. As set out in the Court¿s earlier Scheduling Order, any such motions shall be heard on April 30, 2018. In relation to the motions to strike, the Plaintiffs may file their responding motion records under seal and such records shall be treated by the Registry as confidential. The Plaintiffs shall file a public version of their motion records by no later than April 20, 2018." placed on file on 10-APR-2018

Letter from Plaintiff dated 10-APR-2018 Requesting a direction from the Court that the Plaintiffs' responding motion records for the two motions be to strike be filed under seal. received on 10-APR-2018

Letter from Defendant dated 09-APR-2018 Counsel writes in response to the letter from counsel for the Plaintiff and in response to the Order of the Court (Aylen, P) dated April 3, 2018 received on 09-APR-2018

Letter from Plaintiff dated 09-APR-2018 Further to the Courts directon regarding the motion to vary confidentiality Rules in Court files T-401-18 and T-402-18 received on 09-APR-2018

Acknowledgment of Receipt received from Defendant with respect to Scheduling Order (Doc. no. 15) placed on file on 04-APR-2018

Scheduling Order dated 03-APR-2018 rendered by Mandy Aylen, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Case Management Conference Result: "UPON a case management conference held March 28, 2018 to address the timetable for this proceeding and the related action T-402-18;" A motion is to be heard on April 30, 2018 commending at 9:30am (Eastern) at the Federal Court in Ottawa, with video-conferencing to the Federal Court in Toronto. A case management conference is to be helf by teleconference, on April 23, 2018 at 1:00pm (Eastern). The trial of this action is to take place on November 18, 2019 at 9:30am for a duration of ten days, together or consecutively with T-402-18, as determined by the Trial Judge. See attached Scheduling Order for further detail. Filed on 04-APR-2018 entered in J. & O. Book, volume 1365 page(s) 1 - 4 Interlocutory Decision

Solicitor's certificate of service on behalf of Meghan A. Dureen confirming service of doc id 32 upon Plaintiff by e-mail on consent on 04-APR-2018 filed on 04-APR-2018

Book of Authorities consisting of 1 volume(s) on behalf of Defendant received on 04-APR-2018

Solicitor's certificate of service on behalf of Meaghan A. Dureen confirming service of doc 12 upon Plaintiff by e-mail on consent on 03-APR-2018 filed on 03-APR-2018

Motion Record containing the following original document(s): 11 Number of copies received: 3 on behalf of Defendant filed on 03-APR-2018

Written Representations contained within a Motion Record on behalf of Defendant concerning Motion Doc. No. 9 filed on 03-APR-2018

Ottawa 28-MAR-2018 BEFORE Mandy Aylen, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: Direction to issue held by way of Conference Call in chambers Duration per day: 28-MAR-2018 from 01:00 to 02:06 Courtroom : Judge's Chambers - Ottawa Court Registrar: Kathy Craigie Total Duration: 1h6min Appearances: Meghan Dureen, Warren Sprigings, Carol Hitchman 416 777 2273 representing Defendant John Norman, Anthony Creber and Frederick Lussier 613 786 0140 representing Plaintiff Comments: DARS back up not used, at request of the Court Heard together with T-402-18. Direction to follow Minutes of Hearing entered in Vol. 994 page(s) 487 - 496 Abstract of Hearing placed on file

Letter from Plaintiff dated 27-MAR-2018 Further to the Courts direction of the Court Aylen, P dated March 26, 2018 re: proposed timetable. received on 27-MAR-2018

Letter from Defendant dated 27-MAR-2018 Pursuant to the Courts direction of March 26, 2018 Re: proposed timetable in advance of the CMC fixed for March 28, 2018 received on 27-MAR-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 26-MAR-2018 directing that As the parties have indicated that they are only conducting their consultations regarding the proposed timetable for this proceeding today, the parties shall, by no later than 3:00 pm (Eastern) on March 27, 2018, provide the Court with a status update following their discussion and their respective revised proposed timetables to be discussed at the case management conference on March 28, 2018. placed on file on 26-MAR-2018

Solicitor's certificate of service on behalf of Meghan A. Dureen confirming service of Notice to strike on behalf of the Defendant upon Plaintiff by email (with consent) on 26-MAR-2018 filed on 23-MAR-2018

Notice of Motion on behalf of The Defendant, Pfizer Canada returnable (but no hearing date indicated at this time) for an Order pursuant to Rule 221(a) to strike the action filed on 23-MAR-2018

Letter from Defendant dated 23-MAR-2018 re: Motion to strike in Court files T-401-18 and T-402-18. Counsel has attached a Notice of Motion and Certificate of Service in both files. received on 23-MAR-2018

Letter from Defendant dated 23-MAR-2018 With respect to the direction of the Court (Aylen, P) dated March 15, 2018 Counsel includes Pfizers Proposed Schedule received on 23-MAR-2018

Letter from Plaintiffs, Hoffmann-La Rouche dated 23-MAR-2018 Pursuant to the Courts direction dated March 15, 2018. re: Genentech's proposed timetable in T-401-18 and T-402-18 received on 23-MAR-2018

Communication to the Court from the Registry dated 23-MAR-2018 re: File sent to Court re: CMC fixed for March 28 at 1 pm

Affidavit of service of Nancy Gallinger sworn on 22-MAR-2018 on behalf of Defendant confirming service of doc#7 upon Plaintiff by electronic service on 22-MAR-2018 filed on 22-MAR-2018

Reply on behalf of Plaintiff Filed on 22-MAR-2018

Acknowledgment of Receipt received from all parties with respect to direction of the Court (Aylen, P) dated March 15, 2018 placed on file on 15-MAR-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 15-MAR-2018 directing that The Court is in receipt of correspondence from the Plaintiffs seeking to schedule a case management conference in these PMNOC actions, which would we held at the same time as the case management conferences currently scheduled in T-869-17, T-876-17, T-1269-17 and T-1270-17. The Court is not prepared to conduct a case management conference that will seek to set six timetables at the same time. As such, a case management conference will be held on T-401-18 and T-402-18 on March 28, 2018 at 1:00 pm (Eastern). The case management conferences scheduled in T-869-17, T-876-17, T-1269-17 and T-1270-17 on that date are adjourned. The parties shall, by no later than March 22, 2018, provide the Court with their availability for a case management conference in those other four actions that will be held on a date after the case management conference in the PMNOC actions. As the timetable in the PMNOC actions will have an impact on the timing of steps in the other four actions, the parties will need to consider the impact of the PMNOC actions timetable on their proposed timetables in the other four actions and shall provide the Court with revised proposed timetables in the other four actions by no later than three days before the re-scheduled case management conference. The correspondence from the Plaintiffs indicated that the parties will provide the Court with "an update and/or agenda in advance of the case management conference" for the PMNOC actions. This is not sufficient. The Court's Direction dated March 2, 2018 requires that the parties submit their jointly-proposed timetable in accordance with the template provided and indicate for each potential step in the proceeding whether it will apply to the proceeding and if so, the date for completion/filing in relation to each step. Accordingly, the parties shall jointly or absent an agreement, individually, provide the Court with a fully-completed timetable in relation to each applicable step of the proceeding as set out in the template by no later than March 23, 2018." placed on file on 15-MAR-2018

****** CANCELLED ****** Letter from The Plaintiffs HOffman -La Rouche Limited dated 14-MAR-2018 to have the CMC heard together with T-869-17, T-876-17, T-1269-17, T-1270-17 (currently fixed for March 28, 2018 received on 14-MAR-2018

Letter from Plaintiffs, Hoffman-La Roche dated 14-MAR-2018 to have the CMC heard at the same time as T-869-17, T-876-17, T-1269-17 and T-1270-17 (currently fixed for March 28, 2018 received on 14-MAR-2018

Solicitor's certificate of service on behalf of Meghan A. Dureen confirming service of Doc 5 upon Plaintiff by e-mail on 12-MAR-2018 filed on 12-MAR-2018

Defence on behalf of Defendant filed on 12-MAR-2018

Affidavit of service of François Doyon sworn on 05-MAR-2018 on behalf of Plaintiff confirming service of doc. #1 upon Defendant by process server on 02-MAR-2018 filed on 09-MAR-2018

Consent on behalf of all parties to electronic service of all documents not required to be served personally; filed on 08-MAR-2018

Acknowledgment of Receipt received from 2 counsel/parties by fax on 06-MAR-2018 with respect to Order doc. 2 of the Chief Justice, dated 5-MAR-2018 placed on file on 06-MAR-2018

Order dated 05-MAR-2018 rendered by Chief Justice Crampton Matter considered without personal appearance The Court's decision is with regard to Special Case Result: "IT IS ORDERED pursuant to Rule 383 that Prothonotary Mandy Aylen is assigned as Case Management Judge in this matter." Filed on 06-MAR-2018 certified copies sent to 2 counsel/parties by fax on 06-MAR-2018 Transmittal Letters placed on file. entered in J. & O. Book, volume 1362 page(s) 159 - 159 Interlocutory Decision

Acknowledgment of Receipt received from Plaintiff with respect to Direction of the Court Aylen, P dated March 2, 2018 placed on file on 02-MAR-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 02-MAR-2018 directing that As the Plaintiffs are aware, the Plaintiffs are required to requisition a case management conference and provide a jointly-proposed timetable of all steps leading up to trial and dates of mutual availability for trial within seven days of service of the Notice of Intentional to Respond. The Court requires that the parties submit their jointly-proposed timetable in accordance with the attached template and indicate for each potential step in the proceeding whether it will apply to the proceeding and if so, the date for completion/filing in relation to each step. As the Defendant has not yet filed a Notice of Intention to Respond, the Plaintiffs shall provide the Defendant with a copy of this Direction and template forthwith upon being served with the Notice of Intention to Respond. placed on file on 02-MAR-2018

Communication to the Court from the Registry dated 02-MAR-2018 re: Sent to Judicial Administrator on 02-MAR-2018 - CMJ to be assigned - PMNOC.

Letter from Plaintiff dated 01-MAR-2018 informing the Court of four additional proceedings in the Federal Court, in which the Plaintiff's product is also involved, though with different parties than with previously cited proceedings. received on 01-MAR-2018

Covering letter from Plaintiff dated 01-MAR-2018 concerning NOC proceeding, requesting that the proceeding be CM pursuant to Regulation 6.10(1) in accordance with Rules 383, 383.1 and 385 of FCR placed on file on 01-MAR-2018

Statement of Claim filed on 01-MAR-2018 Tariff other action - $150.00